Group structure
20 companies in 3 countries
20 companies in 3 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 185
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| DIGESOL | Bromoprida | Brazil | Authorised | 2012 |
| dipirona monoidratada | Dipirona | Brazil | Authorised | 2007 |
| DIPIRONA SรDICA | Dipirona | Brazil | Authorised | 2009 |
| MALEATO DE DEXCLORFENIRAMINA | Dexclorfeniramina | Brazil | Authorised | 2011 |
| SORISMA N | Naphazoline | Brazil | Authorised | 2012 |
| SULFATO DE SALBUTAMOL | Salbutamol | Brazil | Authorised | 2011 |
| ÁLCOOL ETÍLICO | Brazil | Authorised | 2013 | |
| aftafim | Brazil | Authorised | 2016 | |
| aftafim | Brazil | Authorised | 2015 | |
| aftafim | Brazil | Authorised | 2015 | |
| aftafim | Brazil | Authorised | 2015 | |
| aftafim | Brazil | Authorised | 2015 | |
| aftafim | Brazil | Authorised | 2012 | |
| aftafim | Brazil | Authorised | 2015 | |
| aftafim | Brazil | Authorised | 2016 | |
| AFTAFIM | Brazil | Authorised | 2015 | |
| aftafim | Brazil | Authorised | 2013 | |
| aftafim | Brazil | Authorised | 2015 | |
| aftafim | Brazil | Authorised | 2013 | |
| AFTAFIM | Brazil | Authorised | 2015 | |
| รกlcool etรญlico | Brazil | Authorised | 2012 | |
| ATROVENT 250MCG-2ML UDV (SOLUTION FOR INHALATION) | Ipratropium bromide | Saudi Arabia | Authorised | |
| ATROVENT 500MCG-2ML UDV (SOLUTION FOR INHALATION) | Ipratropium bromide | Saudi Arabia | Authorised | |
| bicarbonato de sรณdio mariol | Brazil | Authorised | 2008 | |
| biodine | Brazil | Authorised | 2007 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Brazil | 176 | 129 | 47 | CompaniesAll medicines |
| Saudi Arabia | 9 | 9 | 0 | CompaniesAll medicines |
Also in the registers of Colombia, Croatia, Malaysia, Serbia, Singapore
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agรชncia Nacional de Vigilรขncia Sanitรกria (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licence: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Keep Unitherโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.